Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...
ROTTERDAM, Netherlands and SAN DIEGO, March 12, 2025 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology and ...
Veridex, LLC , a Johnson & Johnson company, has announced US Food and Drug Administration (FDA) approval of the first intra-operative and gene-based test to detect the spread of breast cancer into the ...
Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node ...
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes — a finding that could ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today ...
Effect of Esthetic Outcome After Breast-Conserving Surgery on Psychosocial Functioning and Quality of Life A beta trial (n = 304) to determine the threshold levels of mammaglobin and cytokeratin 19 ...
Effect of Esthetic Outcome After Breast-Conserving Surgery on Psychosocial Functioning and Quality of Life A beta trial (n = 304) to determine the threshold levels of mammaglobin and cytokeratin 19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results